Sunshine Biopharma Inc - Warrants (15/02/2027)
SBFMW
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.74M
Close$
Share Statistics
| Market cap | $2.74 Million |
|---|---|
| Enterprise Value | $-10,744,962.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-14.4 |
| Beta | 1.31 |
| Outstanding Shares | 1,365,324 |
Return
| Return on Equity | -21.18% |
|---|---|
| Return on Assets | -196.55% |
| Return on Invested Capital | 214.50% |
Valuation & Multiples
| P/E Ratio | -0.11 |
|---|---|
| PEG | 0.97 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.03 |
| Enterprise Value to Revenue | -0.3 |
| Enterprise Value to EBIT | 1.89 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.02 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$-0.12
Average shareholder expectationRevenue Estimate
$8.70 M
Average shareholder expectationNext Earnings Call
Expected Date
November 10, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
$9.60 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.51%▲ 1.97% |
|---|---|
| Total Invested | $1,791▼ 39.19% |
| Investors Holding | 10% |
ESG Score
No data
About Sunshine Biopharma Inc
3 employees